N

NeoPharm Co Ltd
KOSDAQ:092730

Watchlist Manager
NeoPharm Co Ltd
KOSDAQ:092730
Watchlist
Price: 18 950 KRW 0.16% Market Closed
Market Cap: ₩303.8B

Net Margin

21.4%
Current
Improving
by 0.2%
vs 3-y average of 21.2%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
21.4%
=
Net Income
₩27.8B
/
Revenue
₩129.8B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
21.4%
=
Net Income
₩27.8B
/
Revenue
₩129.8B

Peer Comparison

Country Company Market Cap Net
Margin
KR
NeoPharm Co Ltd
KOSDAQ:092730
296.4B KRW
Loading...
FR
L'Oreal SA
PAR:OR
206.8B EUR
Loading...
UK
Unilever PLC
LSE:ULVR
118.9B GBP
Loading...
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.5T INR
Loading...
UK
HALEON PLC
LSE:HLN
33.6B GBP
Loading...
US
Estee Lauder Companies Inc
NYSE:EL
41.6B USD
Loading...
DE
Beiersdorf AG
XETRA:BEI
21.7B EUR
Loading...
JP
Kao Corp
TSE:4452
2.8T JPY
Loading...
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.2T INR
Loading...
IN
Dabur India Ltd
NSE:DABUR
897.6B INR
Loading...
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD
Loading...

Market Distribution

Higher than 93% of companies in Korea
Percentile
93rd
Based on 2 632 companies
93rd percentile
21.4%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

NeoPharm Co Ltd
Glance View

Market Cap
303.8B KRW
Industry
Consumer products

NeoPharm Co., Ltd. engages in the development, manufacture, and sale of cosmetics, medical, and health products. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2007-01-30. The firm produces its products under brand names of ATOPALM, including daily care, intensive care, special care and baby care products; Derma:B, including foam cleansers, oil cleansers, toners, emulsions, creams, facial masks, blemish base (BB) creams, sun protectors, white watering serums, anti-aging eye creams and others; ZEROID, including creams and lotions for recovering damaged skin barriers and hypollalergenic foaming cleansers for atopy and sensitive skins, and others. The company also engages in the original equipment manufacturing (OEM) of skin drugs.

NeoPharm Co Ltd Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
21.4%
=
Net Income
₩27.8B
/
Revenue
₩129.8B
What is NeoPharm Co Ltd's current Net Margin?

The current Net Margin for NeoPharm Co Ltd is 21.4%, which is above its 3-year median of 21.2%.

How has Net Margin changed over time?

Over the last 3 years, NeoPharm Co Ltd’s Net Margin has increased from 21% to 21.4%. During this period, it reached a low of 19.4% on Dec 31, 2024 and a high of 23.9% on Dec 31, 2023.

Back to Top